{
  "actions": [
    {
      "acted_at": "2022-06-06",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2022-06-06",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s4351-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "H001076",
      "district": null,
      "name": "Hassan, Margaret Wood",
      "original_cosponsor": true,
      "sponsored_at": "2022-06-06",
      "state": "NH",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "H000273",
      "district": null,
      "name": "Hickenlooper, John W.",
      "original_cosponsor": true,
      "sponsored_at": "2022-06-06",
      "state": "CO",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000608",
      "district": null,
      "name": "Rosen, Jacky",
      "original_cosponsor": true,
      "sponsored_at": "2022-06-06",
      "state": "NV",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-06-06",
  "number": "4351",
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr6973-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "hr7667-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Enhanced Access to Affordable Medicines Act of 2022",
  "sponsor": {
    "bioguide_id": "R000615",
    "district": null,
    "name": "Romney, Mitt",
    "state": "UT",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-06-06",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2022-06-06",
    "date": "2022-10-18T14:59:49Z",
    "text": "Enhanced Access to Affordable Medicines Act of 2022\n\nThis bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, a revised label for the brand-name drug is approved within 90 days of when the generic is otherwise eligible for approval."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Enhanced Access to Affordable Medicines Act of 2022",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Enhanced Access to Affordable Medicines Act of 2022",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2022-12-29T17:33:53Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s4351.xml"
}